Notably, the upregulation of genes such as HSPA5, HSP90B1, PDIA6, and HERPUD1 correlated closely with the clinical features of EMs, suggesting their potential as biomarkers for EMs diagnosis and prognosis. This evidence concerns the gene HSPA5 and eosinophilia-myalgia syndrome.